Literature DB >> 26165270

Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE).

A Stigliano1, I Chiodini2, R Giordano3,4, A Faggiano5, L Canu6, S Della Casa7, P Loli8, M Luconi6, F Mantero9, M Terzolo10.   

Abstract

Entities:  

Keywords:  Adjuvant treatment; Adrenocortical carcinoma; Mitotane; Overall survival; Prognostic factors; Recurrence-free survival

Mesh：

Substances：

Year:  2015        PMID： 26165270     DOI： 10.1007/s40618-015-0349-9

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  174 in total

1.  Adjuvant and definitive radiotherapy for adrenocortical carcinoma.

Authors:  Aaron Sabolch; Mary Feng; Kent Griffith; Gary Hammer; Gerard Doherty; Edgar Ben-Josef
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-01       Impact factor: 7.038

2.  Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma.

Authors:  Martin Fassnacht; Stefanie Hahner; Buelent Polat; Ann-Cathrin Koschker; Werner Kenn; Michael Flentje; Bruno Allolio
Journal:  J Clin Endocrinol Metab       Date:  2006-08-08       Impact factor: 5.958

Review 3.  Transcriptome analysis of adrenocortical cancers: from molecular classification to the identification of new treatments.

Authors:  Bruno Ragazzon; Guillaume Assié; Jérôme Bertherat
Journal:  Endocr Relat Cancer       Date:  2011-02-23       Impact factor: 5.678

4.  Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial.

Authors:  Alfredo Berruti; Massimo Terzolo; Paola Sperone; Anna Pia; Silvia Della Casa; David J Gross; Carlo Carnaghi; Paolo Casali; Francesco Porpiglia; Franco Mantero; Giuseppe Reimondo; Alberto Angeli; Luigi Dogliotti
Journal:  Endocr Relat Cancer       Date:  2005-09       Impact factor: 5.678

5.  The prognostic value of two different histopathological scoring systems for adrenocortical carcinomas.

Authors:  H P van't Sant; N D Bouvy; G Kazemier; H J Bonjer; W C J Hop; R A Feelders; W W de Herder; R R de Krijger
Journal:  Histopathology       Date:  2007-06-25       Impact factor: 5.087

Review 6.  Adrenocortical cancer: pathophysiology and clinical management.

Authors:  Rossella Libè; Amato Fratticci; Jérôme Bertherat
Journal:  Endocr Relat Cancer       Date:  2007-03       Impact factor: 5.678

7.  Sustained remission with the kinase inhibitor sorafenib in stage IV metastatic adrenocortical carcinoma.

Authors:  Charles Butler; William M Butler; Ali A Rizvi
Journal:  Endocr Pract       Date:  2010 May-Jun       Impact factor: 3.443

8.  Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy.

Authors:  J P Luton; S Cerdas; L Billaud; G Thomas; B Guilhaume; X Bertagna; M H Laudat; A Louvel; Y Chapuis; P Blondeau
Journal:  N Engl J Med       Date:  1990-04-26       Impact factor: 91.245

9.  Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses.

Authors:  Byung Kwan Park; Chan Kyo Kim; Bohyun Kim; Jung Hee Lee
Journal:  Radiology       Date:  2007-06       Impact factor: 11.105

10.  Transcriptional profiling enables molecular classification of adrenocortical tumours.

Authors:  Cecilia Laurell; David Velázquez-Fernández; Kristina Lindsten; Christofer Juhlin; Ulla Enberg; Janos Geli; Anders Höög; Magnus Kjellman; Joakim Lundeberg; Bertil Hamberger; Catharina Larsson; Peter Nilsson; Martin Bäckdahl
Journal:  Eur J Endocrinol       Date:  2009-05-01       Impact factor: 6.664
View more
  16 in total

Review 1.  Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis.

Authors:  R Armignacco; G Cantini; L Canu; G Poli; T Ercolino; M Mannelli; M Luconi
Journal:  J Endocrinol Invest       Date:  2017-10-28       Impact factor: 4.256

Review 2.  Adrenocortical carcinoma: patterns of care and role of adjuvant radiation therapy-a population-based study and review of the literature.

Authors:  S Atallah; H Al-Assaf; Y Xu; S El-Sayed
Journal:  Curr Oncol       Date:  2017-08-31       Impact factor: 3.677

3.  EDP-M plus sintilimab in the treatment of adrenocortical carcinoma: a case report.

Authors:  Zhipeng Zhang; Ningning Liu; Qi Li
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

Review 4.  Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms.

Authors:  Ozgur Mete; Sylvia L Asa; Thomas J Giordano; Mauro Papotti; Hironobu Sasano; Marco Volante
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

5.  Surgical resection of adrenocortical carcinoma with invasion into the inferior vena cava: a case report and literature review.

Authors:  Minchun Jiang; Huanyu Ding; Cheng Li; Kexu Xiang; Juying Tang; Ying Guo; Shaoling Zhang
Journal:  Clin Case Rep       Date:  2017-10-11

6.  The efficacy of radiation therapy in adrenocortical carcinoma: A propensity score analysis of a population-based study.

Authors:  You Luo; San-San Chen; Xiang-Guang Zheng; Li Luo; Sen Wang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

7.  Primary site surgery for metastatic adrenocortical carcinoma improves survival outcomes: an analysis of a population-based database.

Authors:  Sen Wang; Wei-Cheng Gao; San-San Chen; Liang Bai; Li Luo; Xiang-Guang Zheng; You Luo
Journal:  Onco Targets Ther       Date:  2017-11-08       Impact factor: 4.147

8.  Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer.

Authors:  Lidia Cerquetti; Barbara Bucci; Salvatore Raffa; Donatella Amendola; Roberta Maggio; Pina Lardo; Elisa Petrangeli; Maria Rosaria Torrisi; Vincenzo Toscano; Giuseppe Pugliese; Antonio Stigliano
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-24       Impact factor: 5.555

9.  Prognostic Factors for Adrenocortical Carcinoma Outcomes.

Authors:  Claudia Scollo; Marco Russo; Maria Antonietta Trovato; Daniela Sambataro; Dario Giuffrida; Mario Manusia; Giulia Sapuppo; Pasqualino Malandrino; Riccardo Vigneri; Gabriella Pellegriti
Journal:  Front Endocrinol (Lausanne)       Date:  2016-07-25       Impact factor: 5.555

10.  Prognostic Factors of Adrenocortical Carcinoma: An Analysis of the Surveillance Epidemiology and End Results (SEER) Database

Authors:  Sen Wang; San-San Chen; Wei-Cheng Gao; Liang Bai; Li Luo; Xiang-Guang Zheng; You Luo
Journal:  Asian Pac J Cancer Prev       Date:  2017-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.